Article Details

Brookline Capital Management Comments on Apexigen, Inc.'s Q4 2022 Earnings (NASDAQ:APGN)

Retrieved on: 2022-12-16 06:32:29

Tags for this article:

Click the tags to see associated articles and topics

Brookline Capital Management Comments on Apexigen, Inc.'s Q4 2022 Earnings (NASDAQ:APGN). View article details on hiswai:

Excerpt

Finally, BlackRock Inc. acquired a new stake in Apexigen during the third quarter worth about $577,000. Apexigen Company Profile. (Get Rating).

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up